Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies
Authors:
- 1 December 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 22 (6) , 798-803
Abstract
In response to increased resistance to conventional drugs, the WHO is promoting artemisinin-based combination therapy (ACT) for treating uncomplicated malaria. The objective of this report is to review the available evidence on the efficacy and effectiveness, acceptability, and deployment of ACT in resource-limited settings with a focus on sub-Saharan Africa. ACTs are very effective in the treatment of uncomplicated Plasmodium falciparum malaria in children. ACTs are relatively safe and tolerable with no reported resistance in sub-Saharan Africa despite indications of delayed clearance of infections in south-east Asia. The major challenges to the widespread use of ACT include its high cost, availability, and inefficient delivery due to, among other things, weak healthcare systems. ACTs are an essential tool in the fight to control and eliminate malaria. They are currently the most effective drugs against P. falciparum malaria. They should be deployed through programs that address availability, cost, adherence, and quality assurance. Initiatives including home-based management of malaria, improving public sector procurement and supply chains, and reducing private sector pricing should make ACTs more accessible for sub-Saharan African children who bear the brunt of the burden of malarial disease.Keywords
This publication has 44 references indexed in Scilit:
- Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority TrialPLOS ONE, 2009
- Ongoing challenges in the management of malariaMalaria Journal, 2009
- Artemether–lumefantrine: an oral antimalarial for uncomplicated malaria in childrenExpert Review of Anti-infective Therapy, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Efficacy of six-dose regimen of artemether-lumefantrine for the treatment of uncomplicatedfalciparummalaria, three years after its introduction into EthiopiaParasite, 2009
- A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malariaChinese Journal of Integrative Medicine, 2009
- The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparumMalaria Journal, 2009
- Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic testMalaria Journal, 2009
- Malaria case-management under artemether-lumefantrine treatment policy in UgandaMalaria Journal, 2008
- Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional studyBMJ, 2005